A carregar...

Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study

Melanoma of unknown primary (MUP) may have a different biology to melanoma of known primary, but clinical trials of novel therapies (e.g., immune checkpoint or BRAF/MEK inhibitors) have not reported the outcomes in this population. We therefore evaluated the overall survival (OS) among patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Verver, D, van der Veldt, AAM, van Akkooi, ACJ, Verhoef, C, Grünhagen, DJ, Louwman, WJ
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900034/
https://ncbi.nlm.nih.gov/pubmed/30801710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32229
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!